FGF21 and obesity due to melanocortin 4 receptor deficiency: FGF21 treatment alleviated the fatty liver disease in a mouse model of obesity [16,17] in line with its actions on hepatic lipid oxidation and lipolysis in white adipose tissue (WAT).